New Research on Treatment for Ovarian Cancer: More Women Are Now Eligible to Receive a PARP Inhibitor

Published Jul 5, 2019

New Research on Treatment for Ovarian Cancer: More Women Are Now Eligible to Receive a PARP Inhibitor

New research shows that ovarian cancers without BRCA mutations—as well as cancers that haven't responded to chemotherapy in the past—may benefit from PARP inhibitors, too.

NOW
PLAYING
Help Support the Amazing 10-Year-Old With a Rare Cancer Who Sold Her Art to Help With Her Medical Bills
NOW
PLAYING
Would You Buy These Potato Chips Instead of Another Snack Because They’re Pink? The Breast Cancer "Pinkwashing" Effect, Explained
NOW
PLAYING
Creativity & Help From Her Baby Girl Helped This Mom Stay 'Rock Solid' During Second Cancer, Leukemia
NOW
PLAYING
Cancer After 57 Days at Ground Zero: A Retired Firefighter Shares His 9/11 Story
NOW
PLAYING
Chemo During COVID-19: Survivors' Stories and Tips, Plus How Families Can Help
NOW
PLAYING
Continue Cancer Screenings Through COVID-19

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.